Parker Waichman LLP

Financial ties between researchers, drug companies taint clinical data

Much of the so-called clinical data gathered to approve new prescription drugs or used to back marketing claims a company wishes to make about its products is likely soiled by financial ties between the person who wrote the research and the companies using the research to their gain. According to a Washington Post investigation, the […]

financial tiesMuch of the so-called clinical data gathered to approve new prescription drugs or used to back marketing claims a company wishes to make about its products is likely soiled by financial ties between the person who wrote the research and the companies using the research to their gain.

According to a Washington Post investigation, the financial influence of deep-pocketed pharmaceutical companies has extended to the people paid to conduct clinical, supposedly unbiased reviews of drugs. These studies are used by health regulators to determine their risks and benefits and whether they should be approved for sale, and by doctors who frequently consult new data to see who may be at risk of a previously unknown side effect.

Many times nowadays, the company with the new drug is the one paying to have the research performed. And as the rate of dangerous side effects and drug-related injuries and deaths increases and more companies are accused of hiding data that showed a specific pharmaceutical caused a dangerous side effect, it lends to the belief that that drug companies are also peddling influence with the money they pay for this research.

In one specific case, that of the once-popular type 2 diabetes drug Avandia, one single company was able to influence 11 researchers with cash and other endowments to produce research that showed the drug was more effective in regulating blood glucose levels than other popular drug treatments. The validity of the research seemed convincing enough that the respected medical journal New England Journal of Medicine published a 17-page report on the study.

The study was reviewing data from an ongoing clinical trial of Avandia and based on the results at that point, the study found that Avandia was more effective than other drug treatments but those researchers apparently missed data – data they probably should have noticed – that pointed to the drug’s Achilles heel, its link to heart attack and death.

Instead of reporting on this trend in the trial of Avandia and including that in the study that GlaxoSmithKline eventually used to market the drug to become of the most widely-prescribed in the U.S. at one point, the study was published without it and Avandia became part of millions of Americans’ drug diet. The result was at least 83,000 heart attacks and deaths, many of which likely could have been avoided if that study had pointed out this one glaring side effect of the drug.

Speculation exists that the 11 people paid to conduct that research were all paid and highly influenced by GSK to produce evidence that showed Avandia was simply a more effective diabetes drug than others. According to the Post report, “Four were employees and held company stock. The other seven were academic experts who had received grants or consultant fees from the firm.”

In the wake of the widespread complications blamed on Avandia, the drug was all but removed from the U.S. and many foreign markets.

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
Thank you very much for helping me get my money but special thanks to Jorge who was always ready to help me with my case, sorry I must make a strong criticism of Michael who never helped me and complicated the process for me, I think he no longer works with this office, thank you Mil Jorge I will give you 5 and up to 20 stars for your work
Alvaro Sanchez
6 months ago
5 Star Reviews 150
I had a wonderful experience dealing with Parker Waichman LLP. Michelle Josama carefully took me through the process and handle my case with speed and Accuracy. Thank you for a everything.
mark mitchell
3 years ago
5 Star Reviews 150
Positive: Professionalism , Responsiveness I had the pleasure of working with Parker Waichman and especially Christina Morace who did a professional and fantastic job keeping me updated with everything. I am truly happy wit tge firm and Christina Morace.
angela Walker
2 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038